Next Article in Journal
Hydrazones of 4-(Trifluoromethyl)benzohydrazide as New Inhibitors of Acetyl- and Butyrylcholinesterase
Next Article in Special Issue
A Review of Bacteriochlorophyllides: Chemical Structures and Applications
Previous Article in Journal
Anti-Cancer Properties of Theaflavins
Previous Article in Special Issue
Crataegus laevigata Suppresses LPS-Induced Oxidative Stress during Inflammatory Response in Human Keratinocytes by Regulating the MAPKs/AP-1, NFκB, and NFAT Signaling Pathways
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Antioxidant and Antibacterial Activity of Essential Oils and Hydroethanolic Extracts of Greek Oregano (O. vulgare L. subsp. hirtum (Link) Ietswaart) and Common Oregano (O. vulgare L. subsp. vulgare)

by
Olga Kosakowska
1,*,
Zenon Węglarz
1,
Ewelina Pióro-Jabrucka
1,
Jarosław L. Przybył
1,
Karolina Kraśniewska
2,
Małgorzata Gniewosz
2 and
Katarzyna Bączek
1
1
Department of Vegetable and Medicinal Plants, Institute of Horticultural Sciences, Warsaw University of Life Sciences-SGGW, Nowoursynowska 166, 02-787 Warsaw, Poland
2
Department of Food Biotechnology and Microbiology, Institute of Food Sciences, Warsaw University of Life Sciences-SGGW, Nowoursynowska 159, 02-776 Warsaw, Poland
*
Author to whom correspondence should be addressed.
Molecules 2021, 26(4), 988; https://doi.org/10.3390/molecules26040988
Submission received: 29 December 2020 / Revised: 2 February 2021 / Accepted: 8 February 2021 / Published: 13 February 2021
(This article belongs to the Special Issue Natural Product-Inspired Molecules: From Weed to Remedy)

Abstract

:
Greek oregano and common oregano were compared in respect of the antioxidant and antibacterial activity of the corresponding essential oils and hydroethanolic extracts in relation with their chemical profile. The chemical composition of essential oils was determined by GC-MS and GC-FID, while extracts (phenolic acids and flavonoids fractions) were analyzed by HPLC-DAD. Based on given volatiles, the investigated subspecies represented two chemotypes: a carvacrol/γ-terpinene/p-cymene type in the case of Greek oregano and a sabinyl/cymyl type rich in terpinen-4-ol in common oregano. Within non-volatile phenolic compounds, rosmarinic acid appeared to dominate in both subspecies. Lithospermic acid B, chlorogenic acid and isovitexin were present only in Greek oregano extracts. However, the total content of flavonoids was higher in common oregano extracts. The essential oil and extract of Greek oregano revealed visibly stronger antibacterial activity (expressed as MIC and MBC) than common oregano, whereas the antioxidant potential (determined by DPPH, ABTS and FRAP) of these extracts was almost equal for both subspecies. In the case of Origanum plants, the potential application of essential oils and extracts as antiseptic and antioxidant agents in the food industry should be preceded by subspecies identification followed by recognition of their chemotype concerning both terpene and phenolics composition.

1. Introduction

In the last decade, special attention has been paid to the search for natural compounds for preserving foods from spoilage microorganisms and oxidation [1,2]. This has become especially urgent due to the progressive withdrawal of commonly used synthetic antioxidants such as, e.g.: butylated hydroxytoluene (BHT), butylated hydroxyanisole (BAH) or propyl galate (PG) [3,4] and as a result of European Union (EU) law, prohibiting the application of antibiotic growth promoters in food production. The common use of in-feed antibiotics in large-scale livestock rearing has contributed to the increase in the resistance among human pathogens. Thus, since 2006 in the EU such practices are no longer acceptable in animal production [5,6]. This situation has caused the need to screen natural substances able to control growth of pathogens and prevent undesirable oxidation reactions in food products. Among foodborne bacteria, several species have gained a particular attention due to their high pathogenicity. Microorganisms such as Bacillus cereus, Salmonella enterica, Escherichia coli, Staphylococcus aureus, and Listeria monocytogenes can infect and intoxicate humans, leading to serious diseases manifested as abdominal pain, nausea, vomiting and diarrhea [7]. Among these, Listeria monocytogenes seems to be the most dangerous since it causes high mortality, especially in the case of pregnant women, newborns, and the elderly [8]. Thus, the search for a new, natural substances being able to control foodborne pathogens is focused on the abovementioned group.
Up to now, several plant-derived secondary metabolites, mainly phenolics, have been described to reveal activities against these pathogens. Among them the most interesting are phenolic acids (e.g., caffeic acids derivatives), flavonoids (e.g., (−)-epicatechin, quercetin), and volatiles, including essential oils and their components, e.g.: thymol, carvacrol or eugenol [9]. The antibacterial activity of phenolic acids is well-documented, especially when regards to rosmarinic acid. This compound shows potential in the control of Bacillus subtilis, Pseudomonas aeruginosa, E. coli, S. aureus, Shigella spp., and Enterobacter [10,11,12]. It has an inhibitory impact on the proteins of the microbial surface recognizing adhesive matrix molecules, what leads to damage to the bacteria cell wall [13]. Moreover, the presence of a carboxylic acidic group enables ionisability and/or the formation of salts with mineral cations, what was also observed in the case of antibiotics such as, e.g. daptomycin [14]. The activity of other phenolic acids, including chlorogenic acid, is based on a similar mechanism of action [2,15]. In the group of phenolic compounds, flavonoids exhibit a strong antibacterial activity expressed in an inhibition of nucleic acid synthesis, inhibition of cytoplasmic membrane function and by disorders in the energy metabolism of bacterial cells [16,17,18]. Volatiles show well-known antibacterial potential, especially essential oils and their components, e.g. carvacrol and thymol. Due to their hydrophobic nature, they are able to cross the lipid bilayer of cell membrane causing a loss of its integrity and leakage of cellular material. Unlike many antibiotics, these compounds gain access to the periplasm of Gram-negative bacteria such as E. coli and Salmonella typhimurium through the porin proteins of the outer membrane, and finally damage it irreversibly [19,20]. It is worth noting that the precursor of carvacrol, p-cymene, is not an effective antibacterial agent when used alone. However, when combined with carvacrol, synergism has been observed. When p-cymene is incorporated into the lipid bilayer, the transport of carvacrol is visibly facilitated [1,21]. Thus, the works on antibacterial and antioxidant activity should focus not only on single compounds but especially on complex extracts or their fractions.
The phenolic compounds listed above, especially phenolic monoterpenes (carvacrol and thymol) and caffeic acid derivatives (rosmarinic and chlorogenic acids) are known for their high antioxidant potential. Their chemical structure with the presence of phenyl groups makes it possible for them to act as hydrogen atom or electron donors [22,23,24,25,26,27].
Plants rich in the abovementioned compounds are therefore a promising source of natural antimicrobial and antioxidant agents. Among this group, the genus Origanum (Lamiaceae) has gained particular attention because of its interesting chemical composition reflected in a dominance of phenolic compounds in both the volatile and non-volatile fractions [28]. O. vulgare, with six subspecies identified within this taxon, is an aromatic perennial sub-shrub, characterized by a high intraspecific variability. Each subspecies is associated with a main chemotype created on the basis of the ‘sabinyl’ or ‘cymyl’ pathways of monoterpenes biosynthesis, where only the second one leads to the formation of phenolic monoterpens (thymol/carvacrol) [29,30,31]. Two O. vulgare subspecies are especially important from an economic viewpoint, namely Origanum vulgare L. subsp. hirtum (Link) Ietswaart and Origanum vulgare L. subsp. vulgare. The first one also called Greek oregano, originates from the Mediterranean region and is especially valued due to the presence of pure carvacrol chemotypes (up to 80% carvacrol in the essential oil) [32,33]. The second one (common oregano) occurs on the Northern and Central Europe area as the only representative of the genus [34]. Both are cultivated and used commercially in the pharmaceutical, food and cosmetic industries and are known not only for antioxidant and antimicrobial, but also diuretic, expectorant, stimulative, carminative, antispasmodic, and anticancer activities [35,36,37]. It is known that antioxidant and antimicrobial activity of oregano-derived products is associated with the predominance of carvacrol and/or thymol in its essential oil followed by rosmarinic acid and its derivatives within the non-volatile fraction [1,9,22,33,38,39,40]. Although there is a large literature database concerning this issue, some problems are apparent. Previous studies on O. vulgare subspecies are numerous, however they seem to be incomplete, since their biological activities have usually been determined separately from the chemical composition. Given the subtle morphological differences between O. vulgare subspecies, they are often confused, not discriminated and/or treated as a collective taxon. Taking into account that each subspecies is usually assigned to its corresponding main chemotype (conditioning its biological properties), such mistakes may lead to wrong conclusions, especially when a raw material’s activity and application are concerned [33]. Another problem is related with the extraordinary variability of O. vulgare, where each subspecies itself is able to form various morphologically undistinguishable chemotypes [41,42,43,44]. These altogether may cause evident difficulties in practice, since non-phenolic chemotypes will not display the expected biological activity. It seems that in order to counteract such problems, oregano herb standardization should include subspecies identification combined with chemotype recognition.
The aim of the present study was to compare O. vulgare L. subsp. hirtum and O. vulgare L. subsp. vulgare, in respect of antioxidant and antibacterial activity of the corresponding essential oils and hydroethanolic extracts in relation with their chemical profile.

2. Results and Discussion

2.1. Essential Oil Content and Composition

The content of essential oil in the Greek oregano herb was at a level of 2.87 g × 100 g−1 DW, while in common oregano it was distinctly lower and amounted to only 0.53 g × 100 g−1 DW (Table 1). These results are in a good agreement with the data of other authors [30,31,33,45,46,47,48]. It is known that the content of essential oil in O. vulgare subspecies strongly depends on its geographical origin. Greek oregano together with other southernmost subspecies (subsp. glandulosum and subsp. gracile) are considered to be rich in volatiles, whereas common oregano, similarly to the other subspecies originating from central part of Europe (subsp. virens and subsp. viride), is regarded as a rather poor source of these compounds [45].
In the present work, 22 compounds were identified in Greek oregano essential oil, comprising 98.71% of the total identified fraction. In common oregano, 29 compounds were identified, amounting to 99.19%. Monoterpenes, with a predominance of monoterpene hydrocarbons, were the fundamental components of both analyzed essential oils. In Greek oregano, γ-terpinene and p-cymene were present in the highest amounts within this group. A considerable content of phenolic monoterpenes (39.79%) with a clear domination of carvacrol was also noticed in the case of this subspecies (Table 1). Such data are closely related to the literature [33,42,46,47,48,49]. The chemical composition of analyzed Greek oregano essential oil allowed us to classify the oil as a mixed carvacrol/γ-terpinene/p-cymene chemotype. It is known that this subspecies creates various pure or mixed chemotypes, where the most common are those with carvacrol and/or thymol as dominant components, as well as γ-terpinene and/or p-cymene-rich ones. Regarding industrial applications, the pure carvacrol chemotype (with up to 80% of carvacrol) is considered as the most valuable due to proven biological activity of this phenolic monoterpene [35]. This is reflected in European Pharmacopeia recommendation, where the sum of thymol and carvacrol in Greek oregano essential oil should not be lower than 60% [50].
In common oregano essential oil, sabinene and p-cymene dominated within the monoterpene hydrocarbons group (16.41 and 10.45%, respectively). In contrast to Greek oregano, phenolics (carvacrol and thymol) were present in much smaller quantities (7.11%) in favor of the oxygenated monoterpenes (21.19%) where terpinen-4-ol represented up to 13.81%. Common oregano essential oil was rich in sesquiterpenes, especially β-caryophyllene (6.87%) and its oxide (3.39%) (Table 1). The predominance of the abovementioned compounds allows us to qualify the essential oil as a mixed sabinyl/cymyl type rich in terpinen-4-ol. According to the literature, sabinyl chemotypes are considered to be the most frequent within common oregano, while the presence of phenolic ones is rather rare [30,31]. Common oregano is characterized by higher levels of terpenic polymorphism than Greek oregano, since a lot of different chemotypes have been recognized within this subspecies, as follows: sabinene, cis-sabinene hydrate, terpinen 4-ol, p-cymene + β-caryophyllene, germacrene d + β-caryophyllene, etc. [41,43,52,53].

2.2. Phenolic Compounds Composition

Greek oregano and common oregano hydroethanolic extracts differed in the content of determined phenolic acids and flavonoids. Regarding phenolic acids, five compounds were identified, namely: protocatechuic, caffeic, chlorogenic, rosmarinic and lithospermic B acids. In both subspecies, rosmarinic acid was the dominant compound (10,809.37 mg × 100 g−1 in Greek oregano and 8260.68 mg × 100 g−1 in common oregano). In the case of Greek oregano, the high content of rosmarinic acid was followed by a considerable amount of lithospermic acid B (7065.67 mg × 100 g−1) and chlorogenic acid (56.81 mg × 100 g−1). Interestingly, both compounds were not found in common oregano. In general, protocatechiuc, caffeic and chlorogenic acids were detected in visibly lower quantities in comparison to rosmarinic and lithospermic B ones. The content of caffeic acid appeared to be similar both in Greek oregano and common oregano (98.55 and 91.98 mg × 100 g−1, respectively), whereas the content of protocatechuic acid was almost three times higher in common oregano extract when compared to Greek oregano (Table 2). The presence of the above listed compounds in Origanum subspecies and the domination of rosmarinic acid was reported earlier by other authors [44,54,55,56,57]. According to Węglarz et al. [55] common oregano contains also p-hydroxybenzoic, vanillic and o-coumaric acid, while Raduciene et al. [54] showed the presence of chlorogenic acid in this subspecies. The results obtained by Grevsen et al. [44] indicate that Greek oregano is a rich source not only of rosmarinic acid, but also of lithospermic acid B and its derivative (epi-lithospermic acid B), what is in an agreement with our work. It is worth noting that the level of rosmarinic acid is quite variable between O. vulgare chemotypes [58]. For instance, in research performed by Lukas et al. [30], the content of this compound varied from 0.6 to 37.2 mg × g−1 in common oregano populations growing wild in Austria. Such a wide range of content suggests that rosmarinic acid, like terpenes, may be used as a marker of intraspecific variability. Moreover, when given its biological activity, this acid in plant material appears to be desirable from a pharmacological point of view [59,60].
In our study, six compounds were identified within the flavonoids group, as follows: luteolin 7-O-glucoside, apigenin 7-O-glucoside, naryngenin, isovitexin, (+)-catechin and (−)-epicatechin. Both, in Greek oregano and common oregano extracts, luteolin 7-O-glucoside and naryngenin were the dominant species. However, common oregano was characterized by a distinctly higher content of these substances. In turn, Greek oregano extracts were richer in (−)-epicatechin (Table 2). The content of apigenin 7-O-glucoside and (+)-catechin was similar in the extracts of both subspecies, whereas isovitexin was present only in Greek oregano. The obtained results correspond well with the literature data where the domination of luteolin, apigenin and naryngenin derivatives in Origanum subspecies was reported [38,44,54,55,56,57,61]. In Greek and common oregano, other non-methylated flavonones were noticed to be present in high amounts as well, namely eridictyol and its 6,8-di-C-glucoside [44,54,61]. According to Skoula et al. [61] many free flavones, flavonols, flavanones and dihydroflavonols have been identified within this taxon. Gonzalez et al. [56] claimed that the profile of phenolic compounds may be considered as a specific fingerprint useful in the case of authentication and/or discrimination of various Origanum subspecies.

2.3. Antioxidant Activity

The obtained results show that the antioxidant potential both of Greek oregano and common oregano essential oils and hydroethanolic extracts is similar (Table 3). The activity of essential oil derived from Origanum plants was reporter earlier by other authors [1,9,62,63]. According to Kulisic et al. [9], Greek oregano essential oil reveals remarkable antioxidant potential, comparable with α-tocopherol and the synthetic antioxidant butylated hydroxytoluene (BHT). Such an effect is considered to be related with the predominance of carvacrol and/or thymol in the essential oil. However, other monoterpenes, especially oxygenated ones, can also exhibit significant antioxidant activities [64]. When occurring together, these substances are suspected to act synergistically [9]. This may explain the similarity in the antioxidant power of Greek oregano and common oregano essential oils observed in the present study. Although common oregano essential oil contained small content of carvacrol and thymol, it was rich in other monoterpenes both oxygenated and hydrocarbons (52.99 and 21.19%, Table 1), probably responsible for its high antioxidant potential. These results are in a good agreement with data shown by Vazirian et al. [65], where common oregano essential oil, rich in oxygenated monoterpenes, revealed considerable antioxidant activity.
The antioxidant potential of selected extracts obtained from some Origanum subspecies has been already recognized [38,66,67,68]. Based on these data, it seems that the antioxidant activity is related to the solvent polarity, however, some inconsistency may be noticed there. For instance, Kaurinovic et al. [66] and Martins et al. [38] indicate on the aqueous extract as the most effective one, while Licina et al. [67] higlighted the ethanolic extract. It is worth noting that aqueous extracts are rarely used in the industry, in favor of hydroethanolic ones. The results obtained in the present study show that the antioxidant power of hydroethanolic extracts from Greek oregano and common oregano was at a similar level (Table 3). As it was mentioned earlier, the antioxidant activity of plants extracts is usually attributed to the presence of phenolic compounds, mainly phenolic acids and flavonoids. However, the chemical composition of phenolic’s fraction of investigated extracts was not identical (Table 2). Greek oregano extract includes a considerable content of lithospermic acid B, regarded as a strong antioxidant agent [69]. Nevertheless, common oregano extract contains four times more naryngenin, a flavonoid aglycon known for its high antioxidant power [70]. In general, common oregano extract is characterized by higher content of flavonoids, while Greek oregano contains more phenolic acids. This might provide to almost equal antioxidant activity of both investigated extracts

2.4. Antibacterial Activity

In order to express the antibacterial activity of investigated essential oils and hydroethanolic extracts against selected Gram-negative (E. coli ATCC 25922, E. coli O157:H7 ATCC 700728, S. enteritidis ATCC 13076) and Gram-positive (B. cereus ATCC 11778, L. monocytogenes ATCC 7644, S. aureus ATCC 25923) pathogenic microorganisms, MIC and MBC was determined. Essential oils and extracts were tested against standard reference strains of bacteria related to foodborn diseases. The study involved microdilution method, which is a well-suited technique for screening of numerous combinations of antimicrobial agents in relation to different bacteria. Moreover, this method is economical in terms of time and resources [71,72]. The value of bacteriostatic (MIC) and bactericidal (MBC) concentration of essential oils was presented in Table 4.
In general, the activity of Greek oregano essential oil against the tested bacterial strains was at least three times higher when compared to the activity of common oregano essential oil. Here, Greek oregano essential oil effectively inhibited the growth of both Gram-negative and Gram-positive bacteria, with MIC values ranging from 0.25 to 1 mg × mL−1 and MBC values from 0.5 to 2 mg × mL−1. In turn, common oregano essential oil showed higher MIC values (2–8 mg × mL−1) and MBC (4–16 mg × mL−1), which is equivalent to less effective antibacterial activity compared of Greek oregano essential oil. Moreover, common oregano essential oil showed the weakest bacteriostatic and bactericidal activity on S. aureus ATCC 25923 in the examined range of concentrations (MIC = 32; MBC = 64 mg × mL−1). Taking into account MIC and MBC values, E. coli ATCC 25922 and O157:H7 ATCC 700728 appeared to be the most susceptible bacteria among tested strains. It seems that Gram-negative bacteria were more sensitive to the essential oils used in comparison to Gram-positive ones (Table 4). The observed antibacterial activity of essential oils may be related with their chemical composition. One mode of action of essential oil compounds (especially thymol and carvacrol) is the rapid depletion of the intracellular ATP pool through the reduction of ATP synthesis. As a result, the decrease of intracellular ATP content followed by proton motive force finally enhance the permeability of the membrane. The leakage of ions from the cell provide to membrane damage resulting in disturbances of the osmotic pressure of the cells [5,73,74,75]. In general, the antibacterial activity of Origanum genus essential oils is widely described in literature [33,38,75,76,77]. However, the comparison of the activity among different subspecies of the genus is rater scarce. Results obtained in the present study indicate on stronger antimicrobial activity of Greek oregano essential oil than common oregano. This may be explained by higher content of carvacrol (37.21%) followed by p-cymene (10.45%) in this essential oil (Table 1).
The antibacterial activity of hydroethanolic extracts from Greek oregano and common oregano against tested strains was also evaluated. Extracts inhibited the growth of all tested strains of bacteria, however, the MIC and MBC values were different. When regards Greek oregano extract, the MIC values were in range 2–4 mg × mL−1 and MBC from 4 to 8 mg × mL−1. Such results indicate on its effective antibacterial activity. In the case of common oregano extract, visibly higher concentration was applied in order to inhibit the growth of bacteria, especially Gram-negative strains. The weakest antibacterial activity was demonstrated by common oregano extract against S. enteritidis (MIC 64 mg × mL−1 and MBC > 64 mg × mL−1). The MIC and MBC values of those extracts against Gram-positive bacteria was in range of 4–8 mg × mL−1 (MIC) and 8–16 mg × mL−1 (MBC), except for S. aureus for which the MIC and MBC value was 32 mg × mL−1 and 64 mg × mL−1, respectively (Table 4). It was observed that Gram-negative bacteria were more resistant to investigated extracts when compared to Gram-positive strains. According to Martins et al. [38], hydroethanolic extracts obtained from O. vulgare inhibited the growth of E. coli and P. aeruginosa strains, while Licina et al. [67] demonstrated the antibacterial activity of such extracts against Bacillus and S. aureus. However, the abovementioned studies didn’t include the identification of O. vulgare subspecies. In general, the antibacterial activity of extracts investigated in our work may be associated with its chemical composition, especially when given phenolic acids fraction in which rosmarinic acid dominated. Visibly lower antibacterial activity of common oregano extract in comparison to Greek oregano, may be related with the absence of particular phenolic compounds such as lithospermic B and chlorogenic acids combined with the lower content of rosmarinic acid and (−)-epicatechin. These results correspond to those obtained by Sahin et al. [76] indicating that common oregano methanolic extract did not reveal antibacterial activity at all.

3. Materials and Methods

3.1. Plant Material

The objects of the study were two Origanum vulgare subspecies, i.e.: Greek oregano (O. vulgare subsp. hirtum; accession numbers: 406734) and common oregano (O. vulgare subsp. vulgare; accession number: 401204) cultivated at the experimental field of the Department of Vegetable and Medicinal Plants, Warsaw University of Life Sciences (WULS-SGGW) (5210180 N; 2105234 E). The seed material originated from Polish Genebank (National Centre for Plant Genetic Resources: Polish Genebank). The research was carried out on selected clones of the abovementioned accessions (one per each subspecies). The herb (upper, not woody parts of shoots) of both subspecies was harvested in June 2020, from 2-years-old plants, at the beginning of plant’s blooming. Plant material was dried at 35 °C and subjected to chemical analysis.

3.2. Preparation of Essential Oils

60 g of air-dried raw material was hydrodistillated 3 h using a Deryng-type apparatus [78]. Obtained essential oils were stored in dark vials at 4 °C.

3.3. Preparation of Hydroethanolic Extracts

Air-dry, powdered raw material (10 g) was extracted with 100 mL of solvent (ethanol:water; 60:40, v/v) in Büchi Extraction System B-811 (Büchi Labortechnik AG, Flawil, Switzerland). Soxhlet hot extraction with twenty-five cycles was used. In order to obtain sufficient amount of extracts, the extraction was repeated 10 times. Obtained extracts were filtered, concentrated using a rotary evaporator Büchi R200 (Büchi Labortechnik AG), frozen in −80 °C for 5 days, and finally lyophilized (Labconco Freezone 2.5, Labconco, Kansas City, MO, USA). Dry extracts were powdered and stored in dark vials, at 4 °C.

3.4. Chemical Analysis

The chemical composition of essential oil was determined using GC-MS and GC-FID (3.4.1), while the chemical composition of phenolic acids and flavonoids was analyzed by HPLC (see Section 3.4.2). All measurements were performed in triplicate.

3.4.1. Analysis of Essential Oils by GC-MS and GC-FID

The analysis was performed by usage of an Agilent Technologies 7890A gas chromatograph combined with a flame ionization detector (FID) and MS Agilent Technologies 5975C Inert XL_MSD with Triple Axis Detector (Agilent Technologies, Wilmington, DE, USA). A polar capillary Omegawax® column (30 m × 0.25 mm × 0.25 µm film thickness) was applied. Separation conditions were as follows: oven temperature isotherm at 60 °C for 2 min, then it was programmed from 60 °C to 220 °C at a rate of 4°C per min and held isothermal at 220 °C for 5 min. Separation conditions were previously described by Bączek et al. [79]. Essential oil compounds identification was based on comparison of mass spectra from the Mass Spectral Database, as following: NIST08, NIST27, NIST147, NIST11, Wiley7N2, and on comparison of retention indices (RI) relative to retention times of a series of n-hydrocarbons (C7–C30) with those reported in the literature [51].

3.4.2. Analysis of Phenolic Acids and Flavonoids by HPLC

The parameters of chromatographic separation and integration as well as validation procedure was given earlier by Kosakowska et al. [60]. Validation parameters are presented in Table 5. The content of identified phenolic acids and flavonoids was calculated in mg × 100 g−1 of dry extract.

Validation

Standards were purchased from Sigma Life Science (Merck, Darmstadt, Germany) and ChromaDex® (Irvine, CA, USA) and separately dissolved with MeOH in 25 ml volumetric flask according to the ChromaDex’s Tech Tip 0003: Reference Standard Recovery and Dilution and used as standard stock solutions [80]. Working solutions were prepared by diluting 10 µL and 100 µL of standard stock solutions with methanol in 10 mL volumetric flasks, 500 µL and 1000 µL in 5 mL volumetric flasks as well as 1000 µL in 2 mL volumetric flasks. The working solutions and undiluted stock solutions were injected (1 μL) on a column in six replicates (n = 6) using SIL-20AC HT. Six-point calibration curves were plotted according to the external standard method by correlating concentration with peak area. Curves parameters were calculated with Microsoft Excel 14 (Microsoft, Warsaw, Poland). Signal-to-noise ratio approach were used to determined LOD (S/N of 3:1) and LOQ (S/N of 10:1). The peak table and UV-spectra library (190–450 nm) of individual compounds were also created.

Separation Parameters

The work was performed using a Shimadzu Prominence chromatograph equipped with a SIL-20AC HT auto sampler, SPD-M20A photodiode array detector and LC solution 1.21 SP1 chromatography software (Shimadzu, Kyoto, Japan). Separations were achieved using a 100 mm × 4.60 mm, C18 reversed-phase column, 2.6 μm particles with solid core and porous outer layer (Kinetex™, Phenomenex, Torrance, CA, USA). Binary gradient of mobile phase A (deionised water adjusted to pH 2 with phosphoric acid) and B (ACN) was used as follows: 0 min—12.5% B; 4.0 min—23% B; 6.0 min—50% B; 6.01 min—12.5% B; 8 min—stop. The HPLC conditions were as follows: flow rate 1.5 ml×min−1, oven temperature 40 °C, injection volume 1 μL.

Integration Parameters

Peak identification was carried out by comparison of retention time as well UV-spectra with standards (Table 5).

3.5. Antioxidant Activity

3.5.1. DPPH Scavenging Capacity Assay

The measurement of the DPPH (2,2-diphenylpicrylhydrazyl hydrate) radical scavenging activity was carried out according to Yen and Chen [81] with modifications concerning the time of reaction [82]. Dry hydroethanolic extract (0.25 mg) was dissolved in 1 mL of methanol (2×, 4×, 8×, 16× diluted solutions). Essential oils were also diluted in methanol (concentrations 0.20, 0.40, 0.80, 1.60, and 3.20 mg × mL−1) [83]. Then, 3 mL of methanol and 1 mL of DPPH methanolic solution (0.12 mg × mL−1) were added to 1 mL of the different concentrations of extracts and essential oils. Absorbance was measured after 10 min at 517 nm using a 1700 PharmaSpec UV/Vis spectrophotometer (Shimadzu, Warsaw, Poland). The antioxidant activity of extracts and essential oils was calculated as I = [(AB − AA)/AB] × 100, where I is DPPH inhibition (%); AB is the absorbance of a blank sample (t = 0 min); AA is the absorption of extract solution (t = 10 min). Trolox was used to estimate a standard curve. Results are expressed in μmol Trolox equivalents per g of extract and essential oil.

3.5.2. ABTS Scavenging Capacity Assay

ABTS (2,2’-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid radical caption) was measured according to the method described by Re et al. [84] and Arts et al. [85]. A stock solution was prepared by stirring 7 mM ABTS and 2.45 mM (final concentration) potassium persulfate in water and incubating at room temperature in the dark, for 16 h before use. The concentrated ABTS was diluted with phosphate buffered saline (PBS) to a final absorbance of 0.72 (±02) at 734 nm. Then 1 mL ABTS solution was added to 100 μL of extracts (2×, 4×, 8×, 16× diluted solutions) and 100 μL of essential oil (0.20, 0.40, 0.80, 1.60, and 3.20 mg/ml concentrations). Absorbance of ABTS was measured on a 1700 PharmaSpec UV/Vis spectrophotometer (Shimadzu) after 6 min incubation in dark, at 734 nm. The ability of the test sample to scavenge ABTS was compared to the Trolox standard. The solutions of Trolox were prepared in PBS, such that the final concentrations of the standards were 0.0, 1.25, 2.5, 5.0, 7.5, 10.0 mg × 100 mL−1. The percentage inhibition of ABTS of the test samples were calculated according to the following formula:
% inhibition = [(AB − AA)/AB] × 100
where AB is the absorbance of a blank sample and AA is the absorbance of the test sample. Results are expressed in mg Trolox equivalents per 100 mL of extract.

3.5.3. Ferric Reducing Antioxidant Power Assay (FRAP)

A total of 0.25 mg of dry hydroethanolic extract was dissolved in 10 mL of methanol. The working reagent was prepared by mixing acetate buffer (300 mM, pH 3.6), a solution of 10 mM TPTZ (2,4,6-tris(2-pyridyl)-s-triazine) in 40 mM HCl, and 20 mM FeCl3·6H2O at 10:1:1 (v/v/v) ratio. A total of 100 μL of each properly diluted extract solutions were prepared in tubes with 3 mL of working reagent and shaken for 30 s. After 30 minutes of incubation in a water bath at 37 °C, the absorbance was measured at 593 nm (UV/Vis Shimadzu 1700 PharmaSpec, Shimadzu, Kyoto, Japan). The results were expressed as Trolox equivalent antioxidant capacity in μmol Trolox per g of extract and Fe2+ antioxidant capacity (Fe2+ μmol/g of extract) [86,87].

3.6. Antibacterial Analysis

3.6.1. Target Bacteria and Inoculum Preparation

Reference strains originated from the American Type Culture Collection (ATCC, Manassas, VA, USA). In the study the following Gram-negative bacteria strains were used: Escherichia coli ATCC 25922, Escherichia coli O157:H7 ATCC 700728, Salmonella enterica subsp. serovar Enteritidis ATCC 13076, and Gram-positive bacteria: Bacillus cereus ATCC 11778, Listeria monocytogenes ATCC 7644 and Staphylococcus aureus ATCC 25923.
All bacterial strains were kept frozen in glycerol stocks at −80 °C. Frozen bacterial strains were activate in tryptic soy broth (TSA, BTL, Warsaw, Poland) at 37 °C for 24 h in an aerobic condition. Next, the bacterial strains were transfer and diluted in sterile 0.85% saline solution (NaCl, POCH, Gliwice, Poland) to adjusted 0.5 on the McFarland turbidity scale (Densimat, bioMérieux, Marcy l’Etoile, France), which is equivalent to 1 × 108 CFU × mL−1.

3.6.2. Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC)

Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of essential oils and hydroethanolic dry extracts were determined using microdilution assay [88]. At first, preparation of stock solution of essential oils and extracts were prepared. Essential oils were dissolve in sterile Müller-Hinton Broth (MHB) containing DMSO (40 µL) with 2% of Tween 80, and the final stock solutions were 64 mg × mL−1 Extracts were dissolved directly in sterile MHB and the final stock solutions were 64 mg × mL−1.
Next, a series of twofold dilutions of tested essential oils and extracts in the concentration range from 64 to 0.125 mg × mL−1 were prepared in MHB, using sterile 96-well microtiter plates (Brand, Wertheim, Germany). To each well of plates 10 µL of bacterial inoculum was added and the final concentration of bacteria suspension was about 5 × 105 CFU × mL−1. The well with medium and inoculum without essential oil or extract was also prepared and served as a negative control. In turn, wells with medium and essential oils or extracts without inoculum served as positive controls. The plates with bacteria were incubated at 37 °C for 24 h. The MIC value was defined as the lowest essential oil/extract concentration, in which no visual growth of bacteria was noted. To determine MBC value, 10 µL of broth was taken from the well showing no bacterial growth and spot-inoculated onto plates with Müller-Hinton Agar medium. The plates were incubated at 37 °C for 24h. The MBC was defined as the lowest concentration of essential oil or extract, which resulted in complete reduction of bacteria. Each experiment was performed in triplicate.

3.7. Statistical Analysis

Data were subjected to statistical analysis using Statistica 12 software (Cracow, Poland). The mean values were compared by using the one-way analysis of variance (ANOVA) and expressed as mean with standard deviation (±SD). The differences between individual means were signed as “*” in tables rows and considered to be significant at p < 0.05. Original results (replications) were given in Supplementary Materials (Table S1, Table S2).

4. Conclusions

Greek oregano and common oregano differed in terms of chemical composition and biological activity of essential oils and hydroethanolic extracts. Due to the observed antioxidant potential, it seems that essential oils and extracts of both subspecies may be regarded as a promising source of natural antioxidants. However, considering the antibacterial properties, only Greek oregano should be taken into consideration, since such activity of common oregano essential oil and extracts was rather low. Obtained results are probably associated with various proportions of volatiles (i.a. carvacrol, thymol as well as other monoterpenes) and non-volatiles (i.e., rosmarinic and lithosperimic acid B) that may be responsible for limiting bacteria growth and inactivation of free radicals. To conclude, in the case of the Origanum plants, the potential application of its essential oils and extracts as antiseptic and/or antioxidant agents in the food industry, should be preceded by subspecies identification followed by recognition of their chemotype concerning both terpene and phenolics composition.

Supplementary Materials

The following are available online. Table S1. The chemical composition of phenolic acids and flavonoids in hydroethanolic extracts (mg × 100 g−1)—means with repetitions. Table S2. Antioxidant activity of essential oils and hydroethanolic extracts (DPPH, ABTS, FRAP)—means with repetitions.

Author Contributions

Conceptualization, O.K., Z.W, K.B.; methodology of chemical analysis, O.K., E.P.-J., J.L.P., K.K.; validation, J.L.P.; investigation, O.K., E.P.-J., J.L.P., K.K.; writing—original draft preparation, O.K.; writing—review and editing, O.K., Z.W., K.K., M.G., K.B.; supervision, Z.W., M.G, K.B.; project administration, O.K.; funding acquisition, O.K.; All authors have read and agreed to the published version of the manuscript.

Funding

The studies were funded by the National Science Centre (Poland), within the MINIATURA 3 project (ID 454395; 2019/03/X/NZ9/01612).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Acknowledgments

The technical help of Analytical Centre (WULS-SGGW) is gratefully acknowledged.

Conflicts of Interest

The authors declare no conflict of interest.

Sample Availability

Samples of compounds and plant materials used in the experiment are available from the authors.

References

  1. Castilho, P.C.; Savluchinske-Feio, S.; Weinhold, T.S.; Gouveia, S.C. Evaluation of the antimicrobial and antioxidant activities of essential oils, extracts and their main components from oregano from Madeira Island, Portugal. Food Control 2012, 23, 552–558. [Google Scholar] [CrossRef]
  2. Cetin-Karaca, H.; Newman, M.C. Antimicrobial efficacy of natural phenolic compounds against Gram positive foodborne pathogens. J. Food. Res. 2015, 4, 14–27. [Google Scholar] [CrossRef]
  3. Namiki, M. Antioxidants / antimutagens in food. Crit. Rev. Food Sci. Nutr. 1990, 29, 273–300. [Google Scholar] [CrossRef]
  4. Pokorny, J. Natural antioxidant for food use. Trends Food Sci. Tech. 1991, 9, 223–227. [Google Scholar] [CrossRef]
  5. Franz, C.; Baser, K.H.C.; Windisch, W. Essential oils and aromatic plants in animal feeding—A European perspective. A review. Flavour Frag. J. 2009, 327–340. [Google Scholar] [CrossRef]
  6. European Community (EC). European Regulations Nos. 834 (2007), 889 (2008) and 1831 (2003). Community Regist. Feed Addit. 2008. [Google Scholar]
  7. Bintsis, T. Foodborne pathogens. Aims Microbiol. 2017, 3, 529–563. [Google Scholar] [CrossRef]
  8. Kraśniewska, K.; Kosakowska, O.; Pobiega, K.; Gniewosz, M. The Influence of Two-Component Mixtures from Spanish Origanum Oil with Spanish Marjoram Oil or Coriander Oil on Antilisterial Activity and Sensory Quality of a Fresh Cut Vegetable Mixture. Molecules 2020, 9, 1740. [Google Scholar] [CrossRef]
  9. Kulisic, T.; Radonic, A.; Katalinic, V.; Milos, M. Use of different methods for testing antioxidative activity of oregano essential oil. Food Chem. 2004, 85, 633–640. [Google Scholar] [CrossRef]
  10. Ekambaram, S.P.; Perumal, S.S.; Viswanathan, V. Antibacterial synergy between rosmarinic acid and antibiotics against methicillin-resistant Staphylococcus aureus. J. Intercult. Ethnopharmacol. 2016, 5, 5–363. [Google Scholar] [CrossRef]
  11. Salawu, S.O.; Ogundare, A.O.; Ola-Salawu, B.B.; Akindahunsi, A.A. Antimicrobial activities of phenolic containing extract of some tropical vegetables. Afr. J. Pharm. Pharmacol. 2011, 5, 486–492. [Google Scholar]
  12. Kuhnt, M.; Pröbstle, A.; Rimpler, H.; Bauer, R.; Heinrich, M. Biological and pharmacological activities and further constituents of Hyptis verticillata. Planta Med. 1995, 61, 227–232. [Google Scholar] [CrossRef]
  13. Bais, P.; Walker, T.S.; Schweizer, H.P.; Vivanco, J.M. Root specific elicitation and antimicrobial activity of rosmarinic acid in hairy root cultures of Ocimum basilicum. Plant Physiol. Bioch. 2002, 40, 983–995. [Google Scholar]
  14. Steenbergen, J.N.; Alder, J.; Thorne, G.M.; Tally, F.P. Daptomycin: A lipopeptide antibiotic for the treatment of serious Gram-positive infections. J. Antimicrob. Chemother. 2005, 55, 283–288. [Google Scholar] [CrossRef] [Green Version]
  15. Lou, Z.; Wang, H.; Zhu, S.; Ma, C.; Wang, Z. Antibacterial activity and mechanism of action of chlorogenic acid. J. Food. Sci. 2011, 76, 398–403. [Google Scholar] [CrossRef]
  16. Bylka, W.E.; Matlawska, I.; Pilewski, N.A. Natural flavonoids as antimicrobial agents. JANA. 2004, 7, 21–28. [Google Scholar]
  17. Cushnie, T.P.T.; Lamb, A.J. Antimicrobial activity of flavonoids. Int. J. Antimicrob. Agents. 2005, 26, 343–356. [Google Scholar] [CrossRef]
  18. Cushnie, T.P.T.; Lamb, A.J. Recent advances in understanding the antibacterial properties of flavonoids. Int. J. Antimicrob. Agents 2011, 38, 99–107. [Google Scholar] [CrossRef]
  19. Helander, I.K.; Alakomi, H.L.; Latva-Kala, K.; Mattila-Sandholm, T.; Pol, I.; Smid, E.J.; Leon, G.M.; von Wright, G.; von Wright, A. Characterization of the action of selected essential oils on Gram negative bacteria. J. Agri. Food Chem. 1998, 46, 3590–3595. [Google Scholar] [CrossRef]
  20. Lambert, R.J.W.; Skandamis, P.N.; Coote, P.J.; Nychas, G.J.E. A study of the minimum inhibitory concentration and mode of action of oregano essential oil, thymol and carvacrol. J. Appl. Microb. 2001, 91, 453–462. [Google Scholar] [CrossRef] [Green Version]
  21. Ultree, A.; Bennink, M.H.J.; Moezelaar, R. The phenolic hydroxyl group of carvacrol is essential for action against the food-borne pathogen Bacillus cereus. Appl. Environ. Microbiol. 2002, 68, 1561–1568. [Google Scholar] [CrossRef] [Green Version]
  22. Yan, F.; Azizi, A.; Janke, S.; Schwarz, M.; Zeller, S. Antioxidant capacity variation in the oregano (Origanum vulgare L.) collection of the German National Genebank. Ind.Crop. Prod. 2016, 92, 19–25. [Google Scholar] [CrossRef]
  23. Hong, C.J.; Ho, T.C. Antioxidant activities of caffeic acid and its related hydroxycinnamic acid compounds. J. Agric. Food Chem. 1997, 45, 2374–2378. [Google Scholar] [CrossRef]
  24. Sato, Y.; Itagaki, S.; Kurokawa, T.; Ogura, J.; Kobayashi, M.; Hirano, T.; Sugawara, M.; Iseki, K. In vitro and in vivo antioxidant properties of chlorogenic acid and caffeic acid. Int. J. Pharm. 2011, 403, 136–138. [Google Scholar] [CrossRef] [PubMed]
  25. Bakota, E.L.; Winkler-Moser, J.K.; Berhow, M.A.; Eller, F.J.; Vaughn, S.F. Antioxidant activity and sensory evaluation of a rosmarinic acid-enriched extract of Salvia officinalis. J. Food Sci. 2015, 80, 711–717. [Google Scholar] [CrossRef] [PubMed]
  26. Muňoz-Muňoz, J.L.; Garcia-Molina, F.; Ros, E.; Tudela, J.; Garcia-Canovas, F.; Rodriguez-Lopez, J.N. Prooxidant and antioxidant activities of rosmarinic acid. J. Food Biochem. 2013, 37, 396–408. [Google Scholar] [CrossRef]
  27. Gűlçin, I. Antioxidant activity of caffeic acid (3,4-dihydroxycinnamic acid). Toxicology 2006, 217, 213–220. [Google Scholar] [CrossRef]
  28. Skoula, M.; Harborne, J.B. The taxonomy and chemistry of Origanum. In Oregano: The Genera Origanum and Lippia; Kintzios, S., Ed.; Taylor and Francis: London, UK; New York, NY, USA, 2002; pp. 67–108. [Google Scholar]
  29. Ietswaart, J.H. A Taxonomic Revision of the Genus Origanum; Leiden University Press: The Hague, The Netherlands; Boston, MA, USA; London, UK, 1980. [Google Scholar]
  30. Lukas, B.; Schmiderer, C.; Novak, J. Phytochemical diversity of Origanum vulgare L. subsp. vulgare (Lamiaceae) from Austria. Bioch. Syst. Ecol. 2013, 50, 106–113. [Google Scholar] [CrossRef]
  31. Lukas, B.; Schmiderer, C.; Novak, J. Essential oil diversity of European Origanum vulgare L. (Lamiaceae). Phytochemistry 2015, 119, 32–40. [Google Scholar] [CrossRef]
  32. Oliwier, G.W. The world market of oregano. In Proceedings of the IPGRI International Workshop on Oregano; Padulosi, S., Ed.; CIHEAM Valenzano: Bari, Italy, 1996; pp. 141–146. [Google Scholar]
  33. De Martino, L.; De Feo, V.; Formisano, C.; Mignola, E.; Senatore, F. Chemical composition and antimicrobial activity of the essential oils from three chemotypes of Origanum vulgare L. ssp. hirtum (Link) Ietswaart growing wild in Campania (Southern Italy). Molecules 2009, 14, 2735–2746. [Google Scholar] [CrossRef] [Green Version]
  34. Matuszkiewicz, W. Przewodnik do Oznaczania Zbiorowisk Roślinnych Polski; Państwowe Wydawnictwo Naukowe: Warsaw, Poland, 2011. [Google Scholar]
  35. Baricevic, D.; Bartol, T. The biological/pharmacological activity of the Origanum genus. In Medicinal and Aromatic Plants—Industrial Profiles; Kintzios, S., Ed.; Taylor and Francis: London, UK; New York, NY, USA, 2002; pp. 176–213. [Google Scholar]
  36. Chishti, S.; Kaloo, Z.A.; Sultan, P. Medicinal importance of genus Origanum: A review. J. Pharmacogn. Phytother. 2013, 5, 170–177. [Google Scholar]
  37. Senderski, M.E. Praktyczny Poradnik o Ziołach i Ziołolecznictwie. Liber: Warsaw, Poland, 2009. [Google Scholar]
  38. Martins, N.; Barros, L.; Santos-Buelga, C.; Henriques, M.; Silva, S.; Ferreira, I.C.F.R. Decoction, infusion and hydroalcoholic extract of Origanum vulgare L.: Different performances regarding bioactivity and phenolic compounds. Food Chem. 2014, 158, 73–80. [Google Scholar] [CrossRef] [Green Version]
  39. Nostro, A.; Roccaro, A.S.; Bisignano, G.; Marino, A.; Cannatelli, M.A.; Pizzimenti, F.C.; Cioni, P.L.; Procopio, F.; Blanco, A.R. Effects of oregano, carvacrol and thymol on Staphylococcus aureus and Staphylococcus epidermidis biofilms. J Med. Microbiol. 2007, 56, 519–523. [Google Scholar] [CrossRef] [PubMed]
  40. Chaundry, N.M.A.; Saeed, S.; Tariq, P. Antibacterial effects of oregano (Origanum vulgare) against gram negative bacilli. Pak. J. Bot. 2007, 39, 609–613. [Google Scholar]
  41. Mockute, D.; Bernotiene, G.; Judzěntiene, A. Chemical composition of essential oils of Origanum vulgare L. growing in Lithuania. Biologija 2004, 4, 44–49. [Google Scholar]
  42. Azizi, A.; Hadian, J.; Gholami, M.; Friedt, W.; Honermeier, B. Correlations between genetic, morphological and chemical diversities in a germplasm collection of the medicinal plant Origanum vulgare L. Chem. Biodiv. 2012, 9, 2784–2801. [Google Scholar] [CrossRef] [PubMed]
  43. Kosakowska, O.; Czupa, W. Morphological and chemical variability of common oregano (Origanum vulgare L. subsp. vulgare) occurring in eastern Poland. Herba Pol. 2018, 64, 11–21. [Google Scholar] [CrossRef] [Green Version]
  44. Grevsen, K.; Fretté, X.C.; Christensen, L.P. Content and composition of volatile terpenes, flavonoids and phenolic acids in Greek oregano (Origanum vulgare L. ssp. hirtum) at different development stages during cultivation in cool temperate climate. Eur. J. Hortic. Sci. 2009, 74, 193–203. [Google Scholar]
  45. Kokkini, S. Taxonomy, diversity and distribution of Origanum species. In Proceedings of the IPGRI International Workshop on Oregano; Padulosi, S., Ed.; CIHEAM Valenzano: Bari, Italy, 1997; pp. 122–132. [Google Scholar]
  46. D’Antuono, L.; Galletti, G.; Bocchini, P. Variability of essential oil content and composition of Origanum vulgare L. populations from a north Mediterranean area (Liguria region, Northern Italy). Ann. Bot. 2000, 86, 471–478. [Google Scholar] [CrossRef]
  47. Berghold, H.S.; Wagner, M.M.; Thaller, A.; Müller, M.; Rakowitz, M.; Pasteiner, S.; Boechzelt, H. Ertrag, gehalt und zusammensetzung des ätherischen öls von fünf oregano-zuchtstämmen (Origanum vulgare L.) in abhängigkeitvom entwicklungsstadium. Z. Arzn. Gew. Pfl. 2008, 13, 36–43. [Google Scholar]
  48. Baranauskiene, R.; Venskutonis, P.; Dambrauskiene, E.; Viškelis, P. Harvesting time influences the yield and oil composition of Origanum vulgare L. ssp vulgare and ssp. hirtum. Ind. Crop. Prod. 2013, 49, 43–51. [Google Scholar] [CrossRef]
  49. Shafiee-Hajiabad, M.; Hardt, M.; Honermeier, B. Comparative investigation about the trichome morphology of common oregano (Origanum vulgare L. subsp. vulgare) and Greek oregano (Origanum vulgare L. subsp. hirtum). J. Appl. Res. Med. Aromat. Plants 2014, 1, 50–58. [Google Scholar] [CrossRef]
  50. European Pharmacopoeia. European Directorate for the Quality of Medicines and Health Care (EDQM), 9th ed.; Council of Europe: Strasbourg, France, 2017. [Google Scholar]
  51. Babushok, V.I.; Linstrom, P.J.; Zenkevich, I.G. Retention Indices for Frequently Reported Compounds of Plant Essential Oils. J. Phys. Chem. Ref. Data 2011, 40. [Google Scholar] [CrossRef] [Green Version]
  52. Mockute, D.; Bernotieneė, G.; Judzěentieneė, A. The β-ocimene chemotype of essential oils of the inflorescences and the leaves with stems from Origanum vulgare ssp vulgare growing wild in Lithuania. Bioch. Syst. Ecol. 2003, 31, 269–278. [Google Scholar] [CrossRef]
  53. Chalchat, J.C.; Pasquier, B. Morphological and chemical studies of Origanum clones: Origanum vulgare L. ssp vulgare. J. Essent. Oil Res. 1998, 11, 143–144. [Google Scholar] [CrossRef]
  54. Radusiene, J.; Ivanauskas, L.; Janulis, V.; Jakstas, V. Composition and variability of phenolic compounds in Origanum vulgare from Lithuania. Biologija 2008, 54, 45–49. [Google Scholar] [CrossRef]
  55. Węglarz, Z.; Osińska, E.; Geszprych, A.; Przybył, J. Intraspecific variability of wild marjoram (Origanum vulgare L.) naturally occurring in Poland. Braz. J. Med. Plants 2006, 8, 23–26. [Google Scholar]
  56. González, M.D.; Lanzelotti, P.L.; Luis, C.M. Chemical fingerprinting by HPLC-DAD to differentiate certain subspecies of Origanum vulgare L. Food Anal. Methods. 2017, 10, 1460–1468. [Google Scholar] [CrossRef]
  57. Gutierrez-Grijalva, E.; Picos-Salas, M.A.; Leyva-Lopez, N.; Criollo-Mendoza, M.S.; Vazquez-Olivo, G.; Heredia, J.B. Flavonoids and phenolic acids from oregano: Occurrence, biological activity and health benefits. Plants 2017, 7, 2. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  58. Shen, D.; Pan, M.H.; Wu, Q.L.; Park, C.H.; Juliani, H.R.; Ho, C.T.; Simon, J.E. LC-MS method for the simultaneous quantitation of the anti-inflammatory constituents in oregano (Origanum species). J. Agric. Food Chem. 2010, 58, 7119–7125. [Google Scholar] [CrossRef] [PubMed]
  59. Adomako-Bonsu, A.G.; Chan, S.L.F.; Pratten, M.; Fry, J.R. Antioxidant activity of rosmarinic acid and its principal metabolites in chemical and cellular systems: Importance of physico-chemical characteristics. Toxicol. Vitr. 2017, 40, 248–255. [Google Scholar] [CrossRef]
  60. Kosakowska, O.; Bączek, K.; Przybył, J.; Pawełczak, A.; Rolewska, K.; Węglarz, Z. Morphological and chemical traits as quality determinants of common thyme (Thymus vulgaris L.) on the example of Standard Winter cultivar. Agronomy 2020, 10, 909. [Google Scholar] [CrossRef]
  61. Skoula, M.; Grayer, J.; Kite, G.C.; Veitch, N.C. Exudate flavones and flavanones in Origanum species and their interspecific variation. Biochem. Sys. Ecol. 2008, 36, 646–654. [Google Scholar] [CrossRef]
  62. Milos, M.; Mastelic, J.; Jerkovic, I. Chemical composition and antioxidant effect of glycosidically bound volatile compounds from oregano (Origanum vulgare L. ssp. hirtum). Food Chem. 2000, 71, 79–83. [Google Scholar] [CrossRef]
  63. Tuttolomondo, T.; Salvatore, L.B.; Licata, M.; Virga, G.; Leto, C.; Saija, A.; Trombetta, D.; Tomaino, A.; Speciale, A.; Napoli, E.M.; et al. Biomolecular characterization of wild sicilian oregano: Phytochemical screening of essential oils and extracts, and evaluation of their antioxidant activities. Chem. Biodivers. 2013, 10, 411–433. [Google Scholar] [CrossRef] [PubMed]
  64. Ruberto, G.; Baratta, M.T. Antioxidant activity of selected essential oil components in two lipid model systems. Food Chem. 2000, 69, 167. [Google Scholar] [CrossRef]
  65. Vazirian, M.; Mohammadi, M.; Farzaei, M.H.; Amin, G.; Amanzadeh, Y. Chemical composition and antioxidant activity of Origanum vulgare subsp. vulgare essential oil from Iran. Res. J. Pharm. 2015, 2, 41–46. [Google Scholar]
  66. Kaurinovic, B.; Popovic, M.; Vlaisavlevic, S.; Triviv, S. Antioxidant capacity of Ocimum basilicum L. and Origanum vulgare L. extracts. Molecules 2011, 16, 7401–7414. [Google Scholar] [CrossRef]
  67. Ličina, B.Z.; Stefanović, O.D.; Vasić, S.M.; Radojević, I.D.; Dekić, M.S.; Čomić, L.R. Biological activities of the extracts from wild growing Origanum vulgare L. Food Contrl. 2013, 33, 498–504. [Google Scholar] [CrossRef]
  68. Bendini, A.; Toschi, T.G.; Lercker, G. Antioxidant activity of oregano (Origanum vulgare L.) leaves. Ital. J. Food Sci. 2002, 1, 14. [Google Scholar]
  69. Wang, B. Salvia miltiorrhiza: Chemical and pharmacological review of a medicinal plant. J. Med. Plants Res. 2010, 4, 2813–2820. [Google Scholar]
  70. Cavia-Saiz, M.; Busto, M.D.; Concepci, M.; Ortega, N.; Perez-Mateos, M.; Mu, P. Antioxidant properties, radical scavenging activity and biomolecule protection capacity of flavonoid naringenin and its glycoside naringin: A comparative study. J. Sci. Food Agric. 2010, 90, 1238–1244. [Google Scholar] [CrossRef]
  71. Klancnnik, A.; Piskernik, S.; Jeršek, B.; Možina, S.S. Evaluation of diffusion and dilution methods to determine the antibacterial activity of plant extracts. J. Microbiol. Methods. 2010, 81, 121–126. [Google Scholar] [CrossRef]
  72. Kosakowska, O.; Bączek, K.; Przybył, J.L.; Pióro-Jabrucka, E.; Czupa, W.; Synowiec, A.; Gniewosz, M.; Costa, R.; Mondello, L.; Węglarz, Z. Antioxidant and antibacterial activity of roseroot (Rhodiola rosea L.) dry extracts. Molecules 2018, 23, 1767. [Google Scholar] [CrossRef] [Green Version]
  73. Veldhuizen, E.J.A.; Tjeersma van Bokhoven, J.L.M.; Zweijtzer, C.; Burt, S.A.; Haagsman, H.P. Structural requirements for the antimicrobial activity of carvacrol. J. Agric. Food Chem. 2006, 54, 1874. [Google Scholar] [CrossRef]
  74. Ultree, A.; W. Kets, E.P.; Smid, E.J. Mechanisms of action of carvacrol on the food-borne pathogen Bacillus Cereus. Appl. Environm. Microbiol. 1999, 65, 4606. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  75. Alexopoulos, A.; Plessas, S.; Kimbaris, A.; Varvatou, M.; Mantzourani, I.; Fournomiti, M. Mode of antimicrobial action of Origanum vulgare essential oil against clinical pathogens. Curr. Res. Nutr. Food Sci. 2017, 5, 109–115. [Google Scholar] [CrossRef]
  76. Şahin, F.; Güllüce, M.C.; Daferera, D.; Sökmen, A.; Polissiou, M.M.; Agar, G.; Özer, H. Biological activities of the essential oils and methanol extract of Origanum vulgare in the Eastern Anatolia region of Turkey. Food Control. 2004, 15, 549–557. [Google Scholar] [CrossRef]
  77. Siroli, L.; Patrignani, F.; Montanari, C.; Tabanelli, G.; Bargossi, E.; Gardini, F.; Lanciotti, R. Characterization of oregano (Origanum vulgare) essential oil and definition of its antimicrobial activity against Listeria monocytogenes and Escherichia coli in vitro system and on foodstuff surfaces. Afr. J. Microbiol. Res. 2014, 8, 2746–2753. [Google Scholar] [CrossRef]
  78. Polish Pharmacopoeia. Office of Registration of Medicinal Products, Medical Devices and Biocidal Products, 6th ed.; Polish Pharmaceutical Society: Warsaw, Poland, 2002. [Google Scholar]
  79. Bączek, K.; Kosakowska, O.; Przybył, J.; Kuźma, P.; Ejdys, M.; Obiedziński, M.; Węglarz, Z. Intraspecific variability of yarrow (Achillea millefolium L. s.l.) in respect of developmental and chemical traits. Herba Pol. 2015, 61, 37–52. [Google Scholar] [CrossRef] [Green Version]
  80. Kosakowska, O.; Węglarz, Z.; Pióro-Jabrucka, E.; Przybył, J.L.; Kraśniewska, K.; Gniewosz, M.; Bączek, K. Antioxidant and Antibacterial Activity of Essential Oils and Hydroethanolic Extracts of Greek Oregano (O. vulgar L. subsp. hirtum (Link) Ietswaart) and Common Oregano (O. vulgar L. subsp. vulgare. Molecules 2021, 26, 988. [Google Scholar] [CrossRef]
  81. Yen, G.C.; Chen, H.Y. Antioxidant activity of various tea extracts in relation to their antimutagenicity. J. Agric. Food Chem. 1995, 43, 27–32. [Google Scholar] [CrossRef]
  82. Szlachta, M.; Małecka, M. Właściwości przeciwutleniające herbatek owocowych. Ż.N.T.J 2008, 1, 92–102. [Google Scholar]
  83. Han, F.; Ma, G.Q.; Yan, M.J.L.; Xiong, W.; Shu, J.C.; Zhao, Z.D.; Xu, H.L. Chemical composition and antioxidant activities of essential oils from different parts of the oregano. J. Zhejiang Univ. Sci. B. 2017, 18, 79–84. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  84. Re, R.; Pellegrini, N.; Porteggente, A.; Pannala, A.; Yang, M.; Rice-Evans, C. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic. Res. 1999, 26, 1231–1237. [Google Scholar] [CrossRef]
  85. Arts, M.J.T.J.; Haenen, G.R.M.M.; Voss, H.P.; Basat, A. Antioxidant capacity of reaction products limits the applicability of the Trolox equivalent antioxidant capacity (TEAC) assay. Food Chem. Toxicol. 2002, 42, 45–49. [Google Scholar] [CrossRef]
  86. Benzie, I.F.; Strain, J.J. The ferric reducing ability of plasma (FRAP) as measurement of ‘antioxidant power’-the FRAP assay. Anal. Biochem. 1996, 239, 70–76. [Google Scholar] [CrossRef] [Green Version]
  87. Thaipong, K.; Boonprakob, U.; Crosby, K.; Cisneros-Zevallos, L.; Byrne, H.D. Comparison of ABTS, DPPH, FRAP and ORAC assays for estimating antioxidant activity from guava fruit extracts. J. Food Compos. Anal. 2006, 19, 669–675. [Google Scholar] [CrossRef]
  88. Clinical Laboratory Standards Institute (CLSI). Methods for Dilution Antimicrobial a Susceptibility Tests for Bacteria That Grow Aerobically, 8th ed.; CLSI document M0-A8) Approved Standard; Clinical Laboratory Standards Institute (CLSI): Wayne, PA, USA, 2009. [Google Scholar]
Table 1. The total content (g × 100 g−1 DW) and gas chromatographic composition (% peak area) of essential oil samples.
Table 1. The total content (g × 100 g−1 DW) and gas chromatographic composition (% peak area) of essential oil samples.
NoCompoundRI1RI2Greek OreganoCommon Oregano
1α-thujene10241012–10395.003.24
2α-pinene10291008–10390.350.97
3camphene10741043–10860.980.06
4β-pinene11121085–11304.361.65
5sabinene11261098–11400.0716.41
63-carene11471122–11690.200.00
7α-terpinene11851154–11955.695.36
8D-limonene12041178–12190.381.08
9α-phellandrene12121148–11860.480.00
101.8-cineole12141186–12310.003.57
11(E)-2-hexenal 12161196–12380.130.00
12trans β-ocimene12361211–12510.002.23
13γ-terpinene12501222–126617.215.96
14p-cymene12751246–129111.1310.45
15m-cymene12811244–12790.003.60
16terpinolene12841261–13000.391.98
173-octanol13911372–14080.000.28
181-octen-3-ol14461411–14651.441.28
19linalool15421507–15640.001.44
20β-caryophyllene15941570–16852.886.87
21terpinen-4-ol15971564–16303.6213.81
22cis-terpineol16211616–16440.820.56
23trans-terpineol16741659–17240.301.76
24α-humulene16581637–16890.511.00
25borneol16841653–17282.980.00
26β-bisabolene17411698–17480.002.73
27α-farnesen17491714–17630.001.33
28β-ionone18461798–18920.000.05
29caryophyllene oxide19761936–20230.003.39
30(−)-spathulenol21252074–21500.000.66
31thymol21662100–22050.582.47
32carvacrol22132140–224637.214.64
33α-cadinol22292180–22550.000.36
Total 98.7199.19
Monoterpene hydrocarbons 46.2452.99
Oxygenated monoterpenes 7.7221.19
Phenolic monoterpenes 39.797.11
Sesquiterpene hydrocarbons 3.3911.93
Oxygenated sesquiterpenes 0.004.41
Other compounds 1.571.56
Essential oil content 2.870.53
1 RI—experimental retention index on a polar Omegawax® column; 2 RI—range of retention indices on polar column reported by Babushok et al. [51].
Table 2. The chemical composition of phenolic acids and flavonoids in hydroethanolic extracts (mg × 100 g−1).
Table 2. The chemical composition of phenolic acids and flavonoids in hydroethanolic extracts (mg × 100 g−1).
CompoundGreek OreganoCommon Oregano
Phenolic acids
Protocatechuic acid35.78 ± 0.2499.66 ± 0.51 *
Caffeic acid 98.55 ± 1.2891.98 ± 0.72
Chlorogenic acid 56.81 ± 0.90-
Rosmarinic acid10809.37 ± 552.32 *8260.68 ± 69.61
Lithospermic acid B 7065.67 ± 39.94-
Total18066.188452.32
Flavonoids
Luteolin 7-O-glucoside 611.68 ± 1.88862.16 ± 6.49 *
Apigenin 7-O-glucoside 81.73 ± 1.1875.77 ± 0.40
Naryngenin451.46 ± 5.271196.02 ± 8.14 *
Isovitexin273.44 ± 1.89-
(+)-Catechin14.68 ± 1.0710.08 ± 0.30
(-)-Epicatechin196.74 ± 0.31 *51.47 ± 0.60
Total1629.732195.5
* p < 0.05.
Table 3. Antioxidant activity of essential oils and hydroethanolic extracts (DPPH, ABTS, FRAP).
Table 3. Antioxidant activity of essential oils and hydroethanolic extracts (DPPH, ABTS, FRAP).
Essential oilsExtracts
Method Greek
Oregano
Common
Oregano
Greek
Oregano
Common
Oregano
DPPH
(% RSC)61.76 ± 0.0662.01 ± 0.6170.90 ± 0.0369.83 ± 0.17
(µmol Trolox/g)220.29 ± 2.83218.78 ± 2.68252.10 ± 5.98242.43 ± 1.62
ABTS
(% RSC)68.34 ± 0.3668.58 ± 0.1276.25 ± 0.1279.37 ± 0.60
(µmol Trolox/g)340.08 ± 3.10342.96 ± 2.90381.09 ± 2.40397.22 ± 2.90
FRAP
(Fe 2+ µmol/g)22.64 ± 3.2024.12 ± 1.9029.54 ± 1.9531.10 ± 3.10
(µmol Trolox/g)223.57 ± 2.90238.13 ± 1.70287.80 ± 2.70300.46 ± 2.60
* p < 0.05.; not significant.
Table 4. MIC and MBC values of essential oils and hydroethanolic extracts.
Table 4. MIC and MBC values of essential oils and hydroethanolic extracts.
MIC (MBC)
Essential Oils (mg × mL1)Extracts (mg × mL1)
StrainGreek OreganoCommon OreganoGreek OreganoCommon Oregano
Gram-negative bacteria
E. coli ATCC 259220.25 (0.5)2 (4)4 (4)64 (64)
E. coli O157: H7 ATCC 7007280.25 (0.5)2 (4)4 (4)64 (64)
S. enteritidis ATCC 130760.5 (1)4 (8)4 (4)64 (>64)
Gram-positive bacteria
B. cereus ATCC 117780.5 (1)2 (4)2 (4)4 (8)
L. monocytogenes ATCC 76440.5 (2)8 (16)2 (4)8 (16)
S. aureus ATCC 259231 (2)32 (64)4 (8)32 (64)
Table 5. Validation parameters of the HPLC-DAD analysis (n = 6).
Table 5. Validation parameters of the HPLC-DAD analysis (n = 6).
CompoundPrecision Intraday (CV, %)Rt (min)λ (nm)Precision Interday (CV, %)Calibration EquationR2
(n = 6)
Linear Range (mg × mL−1)LOD
(µg × L−1)
LOQ
(µg × L−1)
Recovery (%)
Protocatechuic acid0.301.422540.80y = 7102.9x + 43850.00.99960.38–380.006.6922.2896.4
Caffeic acid1.002.103251.72y = 2592.9x + 379.60.99961.00–998.402.508.3295.7
Chlorogenic acid0.231.753250.65y = 1708.6x + 7483.20.99980.97–966.7020.4268.10103.2
Rosmarinic acid1.245.203252.12y = 2017.9x + 1100.40.99990.43–434.023.209.82102.6
Lithospermic acid B0.745.342540.92y = 1199.9x − 3549.80.99980.60–601.68.2427.62103.5
Luteolin 7-O-glucoside0.364.103352.67y = 2022.2x −1149.40.99970.19–19.085.0318.12101.4
Apigenin 7-O-glucoside1.144.853352.45y = 2673.3x + 4227.20.99980.20–195.407.5225.8797.8
Naryngenin1.216.952841.89y = 1304.8x + 1983.80.99981.98–396.83.289.79102.9
Isovitexin1.002.153351.33y = 2096.1x − 904.80.99950.36–36.888.6528.4798.3
(+)-Catechin0.341.612031.21y = 8216.4x − 6069.30.99980.95–950.0010.9036.40102.7
(−)-Epicatechin0.682.252031.51y = 7345.1x − 5643.80.99950.47–23.4010.0234.0095.6
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Kosakowska, O.; Węglarz, Z.; Pióro-Jabrucka, E.; Przybył, J.L.; Kraśniewska, K.; Gniewosz, M.; Bączek, K. Antioxidant and Antibacterial Activity of Essential Oils and Hydroethanolic Extracts of Greek Oregano (O. vulgare L. subsp. hirtum (Link) Ietswaart) and Common Oregano (O. vulgare L. subsp. vulgare). Molecules 2021, 26, 988. https://doi.org/10.3390/molecules26040988

AMA Style

Kosakowska O, Węglarz Z, Pióro-Jabrucka E, Przybył JL, Kraśniewska K, Gniewosz M, Bączek K. Antioxidant and Antibacterial Activity of Essential Oils and Hydroethanolic Extracts of Greek Oregano (O. vulgare L. subsp. hirtum (Link) Ietswaart) and Common Oregano (O. vulgare L. subsp. vulgare). Molecules. 2021; 26(4):988. https://doi.org/10.3390/molecules26040988

Chicago/Turabian Style

Kosakowska, Olga, Zenon Węglarz, Ewelina Pióro-Jabrucka, Jarosław L. Przybył, Karolina Kraśniewska, Małgorzata Gniewosz, and Katarzyna Bączek. 2021. "Antioxidant and Antibacterial Activity of Essential Oils and Hydroethanolic Extracts of Greek Oregano (O. vulgare L. subsp. hirtum (Link) Ietswaart) and Common Oregano (O. vulgare L. subsp. vulgare)" Molecules 26, no. 4: 988. https://doi.org/10.3390/molecules26040988

Article Metrics

Back to TopTop